Gene expression and pathway analysis of ovarian cancer cells selected for resistance to cisplatin, paclitaxel, or doxorubicin

被引：0
|
作者：
Cheryl A Sherman-Baust
Kevin G Becker
William H Wood III
Yongqing Zhang
Patrice J Morin
机构：
[1] National Institute on Aging,Laboratory of Molecular Biology and Immunology
[2] National Institute on Aging,Research Resource Branch
[3] Johns Hopkins Medical Institutions,Department of Pathology
来源：
Journal of Ovarian Research | / 4卷
关键词：
Ovarian Cancer; Paclitaxel; Doxorubicin; Drug Resistance; Ovarian Cancer Cell;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Mitochondrial Proteomic Analysis of Cisplatin Resistance in Ovarian Cancer
    Chappell, Nicole P.
    Teng, Pang-ning
    Hood, Brian L.
    Wane, Guisong
    Darcy, Kathleen M.
    Hamilton, Chad A.
    Maxwell, G. Larry
    Conrads, Thomas P.
    JOURNAL OF PROTEOME RESEARCH, 2012, 11 (09) : 4605 - 4614
  • [42] Paclitaxel exposure downregulates miR-522 expression and its downregulation induces paclitaxel resistance in ovarian cancer cells
    Mayuko Miyamoto
    Kenjiro Sawada
    Koji Nakamura
    Akihiko Yoshimura
    Kyoso Ishida
    Masaki Kobayashi
    Aasa Shimizu
    Misa Yamamoto
    Michiko Kodama
    Kae Hashimoto
    Tadashi Kimura
    Scientific Reports, 10
  • [43] Paclitaxel exposure downregulates miR-522 expression and its downregulation induces paclitaxel resistance in ovarian cancer cells
    Miyamoto, Mayuko
    Sawada, Kenjiro
    Nakamura, Koji
    Yoshimura, Akihiko
    Ishida, Kyoso
    Kobayashi, Masaki
    Shimizu, Aasa
    Yamamoto, Misa
    Kodama, Michiko
    Hashimoto, Kae
    Kimura, Tadashi
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [44] Synergistic effects of the sesquiterpene lactone, EPD, with cisplatin and paclitaxel in ovarian cancer cells
    van Haaften, Caroline
    Boot, Arnoud
    Corver, Willem E.
    van Eendenburg, Jaap D. H.
    Trimbos, Baptist J. M. Z.
    van Wezel, Tom
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2015, 34
  • [45] Quercetin inhibits proliferation and increases sensitivity of ovarian cancer cells to cisplatin and paclitaxel
    Maciejczyk, Adam
    Surowiak, Pawel
    GINEKOLOGIA POLSKA, 2013, 84 (07) : 590 - 595
  • [46] Synergistic effects of the sesquiterpene lactone, EPD, with cisplatin and paclitaxel in ovarian cancer cells
    Caroline van Haaften
    Arnoud Boot
    Willem E Corver
    Jaap DH van Eendenburg
    Baptist JMZ Trimbos
    Tom van Wezel
    Journal of Experimental & Clinical Cancer Research, 34
  • [47] Cellular efflux pump and interaction between cisplatin and paclitaxel in ovarian cancer cells
    Kamazawa, S
    Kigawa, J
    Minagawa, Y
    Itamochi, H
    Shimada, M
    Takahashi, M
    Sato, S
    Akeshima, R
    Terakawa, N
    ONCOLOGY, 2000, 59 (04) : 329 - 335
  • [48] Piperlongumine Induces Apoptosis and Synergizes with Cisplatin or Paclitaxel in Human Ovarian Cancer Cells
    Gong, Li-Hua
    Chen, Xiu-Xiu
    Wang, Huan
    Jiang, Qi-Wei
    Pan, Shi-Shi
    Qiu, Jian-Ge
    Mei, Xiao-Long
    Xue, You-Qiu
    Qin, Wu-Ming
    Zheng, Fei-Yun
    Shi, Zhi
    Yan, Xiao-Jian
    OXIDATIVE MEDICINE AND CELLULAR LONGEVITY, 2014, 2014
  • [49] Association between circadian gene CLOCK and cisplatin resistance in ovarian cancer cells: A preliminary study
    Xu, Hai
    Wang, Zhiyin
    Mo, Guoyan
    Chen, Hao
    ONCOLOGY LETTERS, 2018, 15 (06) : 8945 - 8950
  • [50] A comprehensive gene expression profile analysis of prostate cancer cells resistant to paclitaxel and the potent target to reverse resistance
    Che, Ping
    Jiang, Shihao
    Zhang, Weiyang
    Zhu, Huixuan
    Hu, Daorong
    Wang, Delin
    HUMAN & EXPERIMENTAL TOXICOLOGY, 2022, 41
12345